feed,title,long_url,short_url
SeekingAlpha,"After A High-Profile Failure In Melanoma, Nektar Therapeutics' Value Shifts To Its Early-Stage Pipeline",https://seekingalpha.com/article/4499718,
SeekingAlpha,Tech Portfolio: From Hero To Zero,https://seekingalpha.com/article/4499716,
